The Lancet

Outbreaks such as mpox and COVID-19 underscore the need for swift, evidence-based responses to limit their spread and save lives.

Summary Background Overdose response technology or virtual overdose response services are an evolving complementary harm reduction

Summary Background Long COVID is the patient-coined term for the persistent symptoms of COVID-19 illness for weeks, months or years following the acute infection.

Summary Background Diarrhoeal disease poses a significant global health challenge, especially in children under three years old.

In 1948, the pioneering study that introduced streptomycin as the first treatment for tuberculosis (TB) was published, but the rapid onset of drug-resistant strains restricted the long-term benefit of streptomycin monotherapy.

On Sept 15, 2015, in Stockholm, the attendees at the Congress of the European Association for the Study of Diabetes were stunned by the presentation

In the past five years, progress in obesity pharmacology has led to speculation that future obstructive sleep apnoea (OSA) treatment might not

In the field of sleep medicine, the management of obstructive sleep apnoea (OSA) has traditionally been dominated by continuous positive airway pressure (CPAP) therapy.

Summary Background The current tuberculosis (TB) drug development pipeline is being re-populated with candidates, including

Summary Background The 20-year UK Prospective Diabetes Study showed major clinical benefits for people with newly diagnosed type 2